Chelsea have been dealt a major injury setback following reports that defender Maxence Lacroix could be sidelined for several weeks and may not return to action until 2027 after suffering a serious hamstring injury.

The news comes as a blow to Chelsea, who will be hoping to have their defensive options available as the season progresses. Lacroix's absence could force the club to adjust its defensive plans while the French centre-back begins his recovery.

According to the information shared, the injury is serious enough to rule the defender out of France's upcoming international break. His treatment is expected to begin as he focuses on recovering from the hamstring problem.

Hamstring injuries can be particularly frustrating for footballers because recovery depends on the severity of the damage and how the player responds to treatment. Returning too early can increase the risk of aggravating the injury, making careful rehabilitation important.

For Chelsea, losing a centre-back for an extended period could present a challenge, especially if the team needs to manage several fixtures without him. The coaching staff may have to rely on other available defenders to fill the gap during his absence.

The reported possibility of a return in 2027 would mean a lengthy spell on the sidelines, although his actual comeback will depend on his recovery progress and any further medical assessments.

France will also have to make alternative arrangements for the upcoming international fixtures after Lacroix was reportedly ruled out. His absence means the national team will be unable to consider him for selection during the break.

Chelsea supporters will now be hoping the defender responds well to treatment and makes a full recovery. While the reported timeline raises concerns, his health and long-term fitness will remain the priority.

For now, the focus will be on rehabilitation, with fans waiting for further updates on his condition and a clearer indication of when he could return to competitive football.

https://www.facebook.com/share/1ED9rhHANh/